Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PT at $86.67

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned an average recommendation of “Moderate Buy” from the ten analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $86.67.

A number of analysts have recently issued reports on ACHC shares. Deutsche Bank Aktiengesellschaft lifted their price target on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Friday, September 20th. KeyCorp began coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Barclays dropped their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st.

Acadia Healthcare Trading Up 0.1 %

Shares of ACHC opened at $56.96 on Friday. The business’s 50-day moving average price is $71.64 and its 200-day moving average price is $69.88. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a twelve month low of $53.22 and a twelve month high of $87.77. The stock has a market cap of $5.28 billion, a PE ratio of -406.86, a P/E/G ratio of 1.57 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.92 EPS. On average, equities analysts forecast that Acadia Healthcare will post 3.51 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of ACHC. Blue Trust Inc. grew its position in Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares during the period. Mather Group LLC. bought a new stake in Acadia Healthcare during the 1st quarter valued at $48,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Acadia Healthcare during the 2nd quarter valued at $59,000. Finally, nVerses Capital LLC purchased a new position in shares of Acadia Healthcare in the second quarter valued at about $95,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.